Suppr超能文献

癌症中的程序性细胞死亡途径:细胞凋亡、自噬和程序性坏死的综述。

Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis.

机构信息

State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Cell Prolif. 2012 Dec;45(6):487-98. doi: 10.1111/j.1365-2184.2012.00845.x. Epub 2012 Oct 3.

Abstract

Programmed cell death (PCD), referring to apoptosis, autophagy and programmed necrosis, is proposed to be death of a cell in any pathological format, when mediated by an intracellular program. These three forms of PCD may jointly decide the fate of cells of malignant neoplasms; apoptosis and programmed necrosis invariably contribute to cell death, whereas autophagy can play either pro-survival or pro-death roles. Recent bulk of accumulating evidence has contributed to a wealth of knowledge facilitating better understanding of cancer initiation and progression with the three distinctive types of cell death. To be able to decipher PCD signalling pathways may aid development of new targeted anti-cancer therapeutic strategies. Thus in this review, we present a brief outline of apoptosis, autophagy and programmed necrosis pathways and apoptosis-related microRNA regulation, in cancer. Taken together, understanding PCD and the complex interplay between apoptosis, autophagy and programmed necrosis may ultimately allow scientists and clinicians to harness the three types of PCD for discovery of further novel drug targets, in the future cancer treatment.

摘要

程序性细胞死亡(PCD),指细胞凋亡、自噬和程序性细胞坏死,是指当由细胞内程序介导时,任何病理形式的细胞死亡。这三种形式的 PCD 可能共同决定恶性肿瘤细胞的命运;凋亡和程序性细胞坏死总是导致细胞死亡,而自噬可以发挥生存或死亡的作用。最近大量积累的证据为更好地理解癌症的发生和发展提供了丰富的知识,这三种独特类型的细胞死亡。能够破译 PCD 信号通路可能有助于开发新的靶向抗癌治疗策略。因此,在这篇综述中,我们简要概述了凋亡、自噬和程序性细胞坏死途径以及与凋亡相关的 microRNA 调控在癌症中的作用。总之,理解 PCD 以及凋亡、自噬和程序性细胞坏死之间的复杂相互作用,可能最终使科学家和临床医生能够利用这三种 PCD 来发现未来癌症治疗的进一步新的药物靶点。

相似文献

1
Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis.
Cell Prolif. 2012 Dec;45(6):487-98. doi: 10.1111/j.1365-2184.2012.00845.x. Epub 2012 Oct 3.
2
Programmed Cell Death, from a Cancer Perspective: An Overview.
Mol Diagn Ther. 2018 Jun;22(3):281-295. doi: 10.1007/s40291-018-0329-9.
3
Cancer-type-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological target.
Biochem Pharmacol. 2015 Mar 1;94(1):1-11. doi: 10.1016/j.bcp.2014.12.018. Epub 2015 Jan 3.
4
The mechanisms of graphene-based materials-induced programmed cell death: a review of apoptosis, autophagy, and programmed necrosis.
Int J Nanomedicine. 2017 Sep 7;12:6633-6646. doi: 10.2147/IJN.S140526. eCollection 2017.
5
Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer.
Arch Immunol Ther Exp (Warsz). 2013 Feb;61(1):43-58. doi: 10.1007/s00005-012-0205-y. Epub 2012 Dec 11.
6
Programmed cell death and cancer.
Postgrad Med J. 2009 Mar;85(1001):134-40. doi: 10.1136/pgmj.2008.072629.
7
Oridonin: targeting programmed cell death pathways as an anti-tumour agent.
Cell Prolif. 2012 Dec;45(6):499-507. doi: 10.1111/j.1365-2184.2012.00849.x.
8
Programmed cell death in spinal cord injury pathogenesis and therapy.
Cell Prolif. 2021 Mar;54(3):e12992. doi: 10.1111/cpr.12992. Epub 2021 Jan 27.
9
Programmed cell death pathways in hearing loss: A review of apoptosis, autophagy and programmed necrosis.
Cell Prolif. 2020 Nov;53(11):e12915. doi: 10.1111/cpr.12915. Epub 2020 Oct 13.
10
Mitochondrial ROS generation for regulation of autophagic pathways in cancer.
Biochem Biophys Res Commun. 2011 Oct 14;414(1):5-8. doi: 10.1016/j.bbrc.2011.09.046. Epub 2011 Sep 17.

引用本文的文献

1
A Comparison of the Flow Cytometric Analysis Results of Benign and Malignant Serous Tumors of the Ovary.
Cancers (Basel). 2025 Aug 19;17(16):2691. doi: 10.3390/cancers17162691.
5
Unveiling the antioxidant and anti-inflammatory potential of syringic acid: mechanistic insights and pathway interactions.
Front Pharmacol. 2025 Jul 9;16:1615294. doi: 10.3389/fphar.2025.1615294. eCollection 2025.
6
NLRP3 Inflammasome-Mediated Pyroptosis in Diabetic Nephropathy: Pathogenic Mechanisms and Therapeutic Targets.
J Inflamm Res. 2025 Jun 25;18:8399-8418. doi: 10.2147/JIR.S524246. eCollection 2025.
7
Unlocking the therapeutic potential of bioactive compounds in : a new frontier in natural medicine.
3 Biotech. 2025 Jul;15(7):203. doi: 10.1007/s13205-025-04353-y. Epub 2025 Jun 7.
10
To be or not to be: navigating the influence of MicroRNAs on cervical cancer cell death.
Cancer Cell Int. 2025 Apr 18;25(1):153. doi: 10.1186/s12935-025-03786-y.

本文引用的文献

2
Deconvoluting the context-dependent role for autophagy in cancer.
Nat Rev Cancer. 2012 Apr 26;12(6):401-10. doi: 10.1038/nrc3262.
3
Caspase-mediated programmed cell death pathways as potential therapeutic targets in cancer.
Cell Prolif. 2012 Jun;45(3):217-24. doi: 10.1111/j.1365-2184.2012.00814.x. Epub 2012 Mar 20.
4
MicroRNA-modulated autophagic signaling networks in cancer.
Int J Biochem Cell Biol. 2012 May;44(5):733-6. doi: 10.1016/j.biocel.2012.02.004. Epub 2012 Feb 10.
5
6
The Ras protein superfamily: evolutionary tree and role of conserved amino acids.
J Cell Biol. 2012 Jan 23;196(2):189-201. doi: 10.1083/jcb.201103008.
7
8
Cell death pathology: cross-talk with autophagy and its clinical implications.
Biochem Biophys Res Commun. 2011 Oct 22;414(2):277-81. doi: 10.1016/j.bbrc.2011.09.080. Epub 2011 Sep 22.
9
Necroptosis: an emerging form of programmed cell death.
Crit Rev Oncol Hematol. 2012 Jun;82(3):249-58. doi: 10.1016/j.critrevonc.2011.08.004. Epub 2011 Oct 1.
10
Mitochondrial ROS generation for regulation of autophagic pathways in cancer.
Biochem Biophys Res Commun. 2011 Oct 14;414(1):5-8. doi: 10.1016/j.bbrc.2011.09.046. Epub 2011 Sep 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验